Volume 73, Number 9, September 1, 2009
About this course
- Released: 09/01/2009
- Expires: 09/01/2011
Learning Objectives:
Upon completion of the article by Iacono et al., the participant should be able to:
• Discuss the anatomic progression of neuronal hypertrophy and its correlation with Alzheimer disease pathology previously described by the authors
• Discuss the findings from this study regarding neuronal size in patients with asymptomatic Alzheimer disease versus patients with MCI, Alzheimer disease, and normal controls
• Discuss the findings from this study regarding the association of linguistic skills in early life and cognition in late life
Core Competencies:
The article by Iacono et al. covers the following core competency:
• Medical Knowledge
Upon completion of the article by Kuijf et al., the participant should be able to:
• Recognize the typical clinical findings in patients with polyneuropathy associated with IgM monoclonal gammopathy
• Discuss the sensitivity of current western blotting analyses for the determination of anti-myelin-associated glycoprotein (MAG) antibodies in patients with polyneuropathy associated with IgM monoclonal gammopathy
• Discuss the results from this study assessing the sensitivity and specificity of a new ELISA analysis for determination of anti-MAG antibodies
Core Competencies:
The article by Kuijf et al. covers the following core competency:
• Medical Knowledge
Author Disclosures: Refer to Information and Author section available in the Tool Bar for each article.
THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES
ACCREDITATION STATEMENT
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed. Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
MISSION STATEMENT/PROGRAM OBJECTIVES
After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.
PARTICIPANTS
This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.
CREDITS
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed.
The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.
DISCLOSURES
Steven Lewis, MD, has received personal compensation in an editorial capacity for the National Board of Medical Examiners and the American College of Physicians; Paul Schulz, MD, has received personal compensation for activities with Pfizer.
COMMERCIAL SUPPORT
This CME program receives no commercial support.
